Optical Fiber Brush Provides Flexible Imaging Interface
|
By LabMedica International staff writers Posted on 16 Feb 2016 |

Image: Source, input images, shuffled, and reordered images using the optical brush (Photo courtesy of MIT Media lab).
Computational techniques and ultrafast imaging have been combined to create a flexible fiber interface for imaging, with no need for lenses or a protective housing.
Developed by researchers at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), the imaging “brush” is made of a loose bundle of optical fibers. The fibers are packed onto a detection array at one end, with the positions of the fibers' free ends randomly distributed, and do not need to correspond to the position of the photodetectors in the array. By measuring the differing time of flight (ToF) measurements at which short bursts of light reach the photodetectors, the device can determine the fibers' relative location.
For the prototype version, the researchers used a bundle of 1,100 fibers; perpendicular to the tips of the fibers were two ultrafast lasers which fired short bursts of light. The other end of the bundle was attached to a beam splitter, which was connected to both an ordinary camera and a high-speed camera that can distinguish optical pulses' times of arrival. Since the bursts of light came from two different directions, the software could use the differences in arrival time to produce a two-dimensional map of the positions of the fibers' tips, thus unscrambling the jumbled image captured by the conventional camera.
The 1,100-fiber prototype produced an image of roughly 33 by 33 pixel resolutions. But since the fibers used were off-the-shelf 300 micrometer fibers, building a device with fibers just a few micrometers in diameter could markedly increase the resolution without increasing the bundle size. A commercial application would also use the fibers to both transmit and receive light along individual fibers, and the system would gauge the time they took to reflect back. The study describing the system was published on February 12, 2106, in Nature Scientific Reports.
“Time of flight, which is a technique that is broadly used in our group, has never been used to do such things; previous works have used time of flight to extract depth information. But in this work, I was proposing to use time of flight to enable a new interface for imaging,” concluded lead author Barmak Heshmat, PhD, of the Camera Culture group at the MIT Media Lab. “Our technique does not require a coaxial calibration, offers a flexible field of view and is intrinsically multi-spectral. Therefore, it has significant potential for endoscopy, imaging in turbid media, and near-field batch probing.”
ToF measures the time that it takes for an object, particle, acoustic, electromagnetic, or other wave to travel a distance through a medium. This measurement can be used for a time standard to measure velocity or path length through a given medium, or as a way to learn about the particle or medium. The traveling object may be detected directly, such as by an ion detector in mass spectrometry, or indirectly, such as by light scattered by laser Doppler velocimetry.
Related Links:
Link to image
Developed by researchers at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), the imaging “brush” is made of a loose bundle of optical fibers. The fibers are packed onto a detection array at one end, with the positions of the fibers' free ends randomly distributed, and do not need to correspond to the position of the photodetectors in the array. By measuring the differing time of flight (ToF) measurements at which short bursts of light reach the photodetectors, the device can determine the fibers' relative location.
For the prototype version, the researchers used a bundle of 1,100 fibers; perpendicular to the tips of the fibers were two ultrafast lasers which fired short bursts of light. The other end of the bundle was attached to a beam splitter, which was connected to both an ordinary camera and a high-speed camera that can distinguish optical pulses' times of arrival. Since the bursts of light came from two different directions, the software could use the differences in arrival time to produce a two-dimensional map of the positions of the fibers' tips, thus unscrambling the jumbled image captured by the conventional camera.
The 1,100-fiber prototype produced an image of roughly 33 by 33 pixel resolutions. But since the fibers used were off-the-shelf 300 micrometer fibers, building a device with fibers just a few micrometers in diameter could markedly increase the resolution without increasing the bundle size. A commercial application would also use the fibers to both transmit and receive light along individual fibers, and the system would gauge the time they took to reflect back. The study describing the system was published on February 12, 2106, in Nature Scientific Reports.
“Time of flight, which is a technique that is broadly used in our group, has never been used to do such things; previous works have used time of flight to extract depth information. But in this work, I was proposing to use time of flight to enable a new interface for imaging,” concluded lead author Barmak Heshmat, PhD, of the Camera Culture group at the MIT Media Lab. “Our technique does not require a coaxial calibration, offers a flexible field of view and is intrinsically multi-spectral. Therefore, it has significant potential for endoscopy, imaging in turbid media, and near-field batch probing.”
ToF measures the time that it takes for an object, particle, acoustic, electromagnetic, or other wave to travel a distance through a medium. This measurement can be used for a time standard to measure velocity or path length through a given medium, or as a way to learn about the particle or medium. The traveling object may be detected directly, such as by an ion detector in mass spectrometry, or indirectly, such as by light scattered by laser Doppler velocimetry.
Related Links:
Link to image
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







